Edwards Lifesciences Corp (NYSE:EW)
| 108.41 Delayed Data As of Dec 03 |  -1.41 / -1.28%Today’s Change | 78.44 Today|||52-Week Range 123.27 | +18.83% Year-to-Date |
Latest EW News | Press Releases
No recent news for Edwards Lifesciences Corp.
Today’s Trading
| Previous close | 109.82 |
| Today’s open | 110.69 |
| Day’s range | 107.18 - 111.18 |
| Volume | 3,146,847 |
| Average volume (3 months) | 2,203,982 |
| Market cap | $68.6B |
Data as of 4:00pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | -21.06% |
| Earnings growth (this year) | +21.69% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +0.88% |
| P/E ratio | 46.6 |
| Price/Sales | 13.14 |
| Price/Book | 14.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYKStryker Corp | -0.52 | -0.21% |
| STESteris plc | -1.17 | -0.53% |
| ISRGIntuitive Surgical | -5.61 | -1.71% |
| SNNSmith & Nephew PLC | -0.65 | -1.96% |
Data as of 4:04pm ET, 12/03/2021
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $4.4B |
| Annual profit (last year) | $823.4M |
| Net profit margin | 18.77% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
